MCF Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-46,500
Closed -$92.5K – 797
2026
Q2
$92.5K Sell
46,500
-23,500
-34% -$33.9K ﹤0.01% 550
2026
Q1
$88.9K Hold
70,000
– – ﹤0.01% 515
2025
Q4
$167K Sell
70,000
-5,000
-7% -$13.7K 0.01% 339
2025
Q3
$214K Buy
75,000
+50,000
+200% +$171K 0.01% 239
2025
Q2
$94.2K Hold
25,000
– – 0.01% 318
2025
Q1
$113K Buy
+25,000
New +$132K 0.01% 288

Other funds holding HCAT

MCF Advisors's HCAT Position: Q3 2026 in Review

MCF Advisors sold out of Health Catalyst (HCAT) in Q3 2026, closing a stake of 46,500 shares — an estimated $92.5K sold.

MCF Advisors first reported a position in HCAT in Q1 2025 and held it in 6 quarters. The position peaked at $214K in Q3 2025. 22 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • MCF Advisors reported no remaining Health Catalyst position as of Q3 2026 after selling out during the quarter.
  • MCF Advisors sold 46,500 Health Catalyst shares in Q3 2026, an estimated $92.5K.
  • MCF Advisors first reported a position in Health Catalyst in Q1 2025 and held it in 6 quarters.
  • MCF Advisors's Health Catalyst position peaked at $214K in Q3 2025.
  • 22 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on MCF Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.